4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000950170-24-043502
Director sold 26,270 shares at an average $246.19 ($6,467,491)
- Director acquired 26,270 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRIEDMAN PAUL A Director | 2024-04-08 | Option exercise 10b5-1 | +26,270 | $9.45 | $248,252 | 212,005 | D |
| FRIEDMAN PAUL A Director | 2024-04-08 | Sale 10b5-1 | −1,441 | $242.95 | $350,094 | 210,564 | D |
| FRIEDMAN PAUL A Director | 2024-04-08 | Sale 10b5-1 | −3,730 | $244.12 | $910,566 | 206,834 | D |
| FRIEDMAN PAUL A Director | 2024-04-08 | Sale 10b5-1 | −5,663 | $244.86 | $1,386,646 | 201,171 | D |
| FRIEDMAN PAUL A Director | 2024-04-08 | Sale 10b5-1 | −2,078 | $245.71 | $510,591 | 199,093 | D |
| FRIEDMAN PAUL A Director | 2024-04-08 | Sale 10b5-1 | −5,028 | $246.96 | $1,241,710 | 194,065 | D |
| FRIEDMAN PAUL A Director | 2024-04-08 | Sale 10b5-1 | −3,464 | $247.76 | $858,241 | 190,601 | D |
| FRIEDMAN PAUL A Director | 2024-04-08 | Sale 10b5-1 | −4,866 | $248.59 | $1,209,642 | 185,735 | D |
| Derivatives | |||||||
| FRIEDMAN PAUL A Director | 2024-04-08 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −26,270 | 206,256 | D | ||
| Open-market sales · 26,270 sh · avg $246.19 · $6,467,491 | |||||||
Loading xslF345X05/ownership.xml…